Co-Authors
This is a "connection" page, showing publications co-authored by PATRICK P LIN and DEJKA MARIDA ARAUJO.
Connection Strength
1.816
-
Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma. Cancers (Basel). 2024 Dec 09; 16(23).
Score: 0.249
-
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma? Am J Clin Oncol. 2024 Sep 03.
Score: 0.245
-
Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020. Cancer Epidemiol. 2024 Oct; 92:102627.
Score: 0.243
-
Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol. 2021 07 01; 44(7):361-368.
Score: 0.196
-
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes. Curr Oncol Rep. 2020 10 06; 22(12):124.
Score: 0.187
-
Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis. Sarcoma. 2020; 2020:7192347.
Score: 0.178
-
Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma. 2017; 2017:2016752.
Score: 0.148
-
Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. Ann Surg Oncol. 2017 Aug; 24(8):2145-2154.
Score: 0.147
-
Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons. J Surg Oncol. 2016 Sep; 114(4):490-4.
Score: 0.138
-
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Apr; 5(4):625-641.
Score: 0.059
-
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res. 2012 Dec 29; 2(1):25.
Score: 0.027